lobbying_activities: 1187873

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1187873	788c1432-8c96-4059-a52e-96a42b64eba6	Q4	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2011	fourth_quarter	PHA	Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316)	HOUSE OF REPRESENTATIVES,SENATE	45000		0	0	2012-01-17T13:43:40-05:00